InvestorsHub Logo
Followers 121
Posts 2016
Boards Moderated 0
Alias Born 11/20/2012

Re: None

Saturday, 10/05/2013 9:59:26 PM

Saturday, October 05, 2013 9:59:26 PM

Post# of 403158
There are many people on this board who believe that Leo hit a grand slam when they bought the
entire drug portfolio from the now bankrupt company called Polymedix.
Some think that many of the larger pharm and biotech's missed out but the truth is that it could be that decided to pass on what Polymedix had to offer.
Brilacidin had already been in a phase 2 study and appeared to show good therapeutic efficacy at low doses but 85 % of the patients had suffered with severe numbness and tingling, 5 dropped out and there was at least one severe untoward reaction.
The CEO,Mr. Nicholas Landekic was in the pharmaceutical field for over 25 years and had ties and connections to Bristol Myers Squibb as well as Johnson and Johnson.
Do you honestly believe that he would not have contacted these people and told them of this great opportunity?
No, I believe Leo should have stayed the course and they should pushed to trial Prurisol because it holds such great potential from the preclinical data.
The 2 million dollars could have spent on Prurisol trials.
Never buy things at a fire sale because they may turn out to be wasteful...

.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News